Les courbes de croissance anté- et postnatales en France – recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) et de la Société française de néonatologie (SFN)

Verspyck, É.; Gascoin, Géraldine; Sénat, Marie-Victoire; Ego, Anne; Simon, Laure; Guellec, Isabelle; Monier, Isabelle; Zeitlin, Jennifer; Subtil, D.; Vayssière, Christophe

doi:10.1016/j.gofs.2022.06.008

Cited by 4 publications

(4 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study underscores the benefits of early laparoscopy in expediting patient recovery and highlights the pivotal role of advanced laparoscopic technology in achieving optimal outcomes (Verspyck et al, 2022). Additionally, the importance of tailoring treatment strategies for TOA based on size and clinical severity is emphasized, with a strong emphasis on the timely initiation of antibiotic therapy to ensure effective infection control (Mathelin et al, 2022).…”

Section: Resultsmentioning

confidence: 74%

Ovarian Tube Abscess in an Intrauterine Contraceptive Device User for 5 Years: A Case Report

Kemalasari,

Widiasih

2023

JOSR

View full text Add to dashboard Cite

A tubo-ovarian abscess (TOA) is one of the late complications of untreated Pelvic Inflammatory Disease (PID) and can be life-threatening if the abscess ruptures and results in sepsis.1 It most commonly affects women of reproductive age and nearly 60% of women with TOA are nulliparous.2 The association between tubo-ovarian abscess formation and the presence of an intrauterine device (IUD) is well recognized. It has been suggested that the risk of upper genital tract infection is highest during the immediate period following the insertion of an IUD. We report a case of pelvic inflammatory disease in a 44-year-old woman using an intrauterine contraceptive device (IUD) for more than 5 years, who complained of lower abdominal pain and lumbar pain without fever, and also had a thick-white vaginal discharge. The clinical diagnosis was performed by anamnesis and ultrasound (we found an hypo- hyperechoic mass on the right adnexa size 4.4 x 3.6 x 4.0 cm) and then the patient was treated with triple antibiotics for 3 days. Afterward, the patient was performed using exploring laparoscopy to continue to right salpingo-oophorectomy adhesiolysis left tubectomy, and IUD removal as well. Long-term users of IUDs remain at risk for serious pelvic infections. Every IUD user's patient should be routinely counseled by their gynecologist and tubo-ovarian abscess should be strongly considered in the differential diagnosis of an IUD user who presents with an adnexal mass, abdominal pain, and lumbar pain. The treatment must be a combination of antibiotics and surgery.

show abstract

Section: Resultsmentioning

confidence: 74%

Ovarian Tube Abscess in an Intrauterine Contraceptive Device User for 5 Years: A Case Report

Kemalasari,

Widiasih

2023

JOSR

View full text Add to dashboard Cite

show abstract

“…LGA percentages between charts has led professional and scientific societies to urge that charts be validated to ensure that they 'fit' the population before local use. 9,10 Local validation studies were also recommended by the WHO group when they published their estimated fetal weight charts. 2 In this more straightforward approach to evaluating performance (previously, the main one employed by researchers developing charts), the aim is to assess whether the chart accurately describes the birthweight (or estimated fetal weight) distribution of the population in which it will be applied.…”

Section: Sga Andmentioning

confidence: 99%

“…Another contribution of this study is to show that the percentages of SGA and LGA fetuses differ depending on the chart used, but that risk patterns remain the same. This finding of variation in SGA/LGA percentages between charts has led professional and scientific societies to urge that charts be validated to ensure that they ‘fit’ the population before local use 9,10 . Local validation studies were also recommended by the WHO group when they published their estimated fetal weight charts 2 .…”

mentioning

confidence: 99%

Point: Setting realistic expectations for the evaluation of intrauterine growth charts

Hocquette,

Zeitlin

2023

Paediatric Perinatal Epid

View full text Add to dashboard Cite

“…The full results of this study, together with the French recommendations on intrauterine, birth weight and postnatal growth charts have been published in the French literature 12 . This brief original report aims to summarize the main results regarding the fetal growth chart to be used in France; our approach might be extended to other countries wishing to adopt growth charts that best fit the distribution of fetal growth in their population.…”

Section: Introductionmentioning

confidence: 99%

Which fetal growth charts should be used in France? Position of the French College of Obstetricians and Gynecologists (CNGOF)

Verspyck,

Senat,

Monier

et al. 2024

Intl J Gynecology & Obste

View full text Add to dashboard Cite

ObjectiveTo assess which fetal growth charts best describe intrauterine growth in France defined as the ability to classify 10% of fetuses below the 10th percentile (small for gestational age [SGA]) and above the 90th percentile (large for gestational age [LGA]) in the second and third trimesters.MethodsWe analyzed five studies on fetal ultrasound measurements using three French data sources. Two studies used second and third trimester ultrasound data from a nationwide birth cohort in 2011 (the ELFE study, N = 13 197 and N = 7747); one study used third trimester ultrasound data from on a nationwide cross‐sectional study (the 2016 French National Perinatal Survey, N = 9940); and the last two studies were from the “Flash study” 2014 which prospectively collected ultrasound data from routine visits in the second and third trimesters (N = 4858 and N = 3522). For each study, we reported the percentage of measurements below the 10th percentile or above the 90th percentile, using French, Hadlock's, WHO and Intergrowth (IG) charts.ResultsWHO classified 4.7% and 16.3% of fetuses as having an estimated fetal weight (EFW) <10th and >90th percentiles in the second trimester compared to 3.3% and 34.7% with IG. The percentage of fetuses in the third trimester with an EFW <10th and >90th percentiles, ranged from 9.1% to 9.4% and from 8.0% to 11.1%, respectively, for WHO, and from 3.9% to 4.1% and from 17.3% to 21.6%, respectively, for IG. The WHO and IG charts for head circumference were very similar and performed well. Compared to the WHO charts, the French and Hadlock's charts deviated more frequently from the target percentiles values for EFW and biometric measures.ConclusionIt is recommended to use the WHO charts for the assessment of EFW and ultrasound biometric measurements in France (strong recommendation; low quality of evidence).

show abstract

Les courbes de croissance anté- et postnatales en France – recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) et de la Société française de néonatologie (SFN)

Cited by 4 publications

References 82 publications

Ovarian Tube Abscess in an Intrauterine Contraceptive Device User for 5 Years: A Case Report

Ovarian Tube Abscess in an Intrauterine Contraceptive Device User for 5 Years: A Case Report

Point: Setting realistic expectations for the evaluation of intrauterine growth charts

Which fetal growth charts should be used in France? Position of the French College of Obstetricians and Gynecologists (CNGOF)

Contact Info

Product

Resources

About